447 related articles for article (PubMed ID: 28586179)
1. Improved posttransplant mortality after share 35 for liver transplantation.
Kwong AJ; Goel A; Mannalithara A; Kim WR
Hepatology; 2018 Jan; 67(1):273-281. PubMed ID: 28586179
[TBL] [Abstract][Full Text] [Related]
2. Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
Nekrasov V; Matsuoka L; Kaur N; Pita A; Whang G; Cao S; Groshen S; Alexopoulos S
Transplantation; 2017 Oct; 101(10):2360-2367. PubMed ID: 28319564
[TBL] [Abstract][Full Text] [Related]
3. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
[TBL] [Abstract][Full Text] [Related]
4. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
5. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
[TBL] [Abstract][Full Text] [Related]
6. Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients.
Sotiropoulos GC; Vernadakis S; Paul A; Hoyer DP; Saner FH; Gallinat A
Dig Dis Sci; 2016 Nov; 61(11):3346-3353. PubMed ID: 27538409
[TBL] [Abstract][Full Text] [Related]
7. Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation.
Volk ML; Lok AS; Pelletier SJ; Ubel PA; Hayward RA
Gastroenterology; 2008 Nov; 135(5):1568-74. PubMed ID: 19009713
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of domino liver transplantation compared to deceased donor liver transplantation: a propensity-matching approach.
Geyer ED; Burrier C; Tumin D; Hayes D; Black SM; Washburn WK; Tobias JD
Transpl Int; 2018 Nov; 31(11):1200-1206. PubMed ID: 29907976
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease.
Lai YH; Duan WD; Yu Q; Ye S; Xiao NJ; Zhang DX; Huang ZQ; Yang ZY; Dong JH
World J Gastroenterol; 2015 May; 21(20):6296-303. PubMed ID: 26034365
[TBL] [Abstract][Full Text] [Related]
10. Liver Transplant Survival Index for Patients with Model for End-Stage Liver Disease Score ≥ 35: Modeling Risk and Adjusting Expectations in the Share 35 Era.
Steggerda JA; Kim IK; Todo T; Malinoski D; Klein AS; Bloom MB
J Am Coll Surg; 2019 Apr; 228(4):437-450.e8. PubMed ID: 30594593
[TBL] [Abstract][Full Text] [Related]
11. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
12. Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database.
Rifai G; Anani A; Hanouneh IA; Mohamad B; Matloob A; Lopez R; Zein NN; Alkhouri N
Transplant Proc; 2016 Dec; 48(10):3362-3367. PubMed ID: 27931582
[TBL] [Abstract][Full Text] [Related]
13. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
Kling CE; Perkins JD; Reyes JD; Montenovo MI
Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
[TBL] [Abstract][Full Text] [Related]
14. Improved retransplant outcomes: early evidence of the share35 impact.
Brooks JT; Koizumi N; Neglia E; Gdoura B; Wong TW; Kwon C; Smith TE; Ortiz J
HPB (Oxford); 2018 Jul; 20(7):649-657. PubMed ID: 29500002
[TBL] [Abstract][Full Text] [Related]
15. MELD and prediction of post-liver transplantation survival.
Habib S; Berk B; Chang CC; Demetris AJ; Fontes P; Dvorchik I; Eghtesad B; Marcos A; Shakil AO
Liver Transpl; 2006 Mar; 12(3):440-7. PubMed ID: 16498643
[TBL] [Abstract][Full Text] [Related]
16. Outcomes among older adult liver transplantation recipients in the model of end stage liver disease (MELD) era.
Malinis MF; Chen S; Allore HG; Quagliarello VJ
Ann Transplant; 2014 Sep; 19():478-87. PubMed ID: 25256592
[TBL] [Abstract][Full Text] [Related]
17. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.
Yadav SK; Saraf N; Saigal S; Choudhary NS; Goja S; Rastogi A; Bhangui P; Soin AS
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28497523
[TBL] [Abstract][Full Text] [Related]
18. National Outcomes of Liver Transplantation for Model for End-Stage Liver Disease Score ≥40: The Impact of Share 35.
Nekrasov V; Matsuoka L; Rauf M; Kaur N; Cao S; Groshen S; Alexopoulos SP
Am J Transplant; 2016 Oct; 16(10):2912-2924. PubMed ID: 27063579
[TBL] [Abstract][Full Text] [Related]
19. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.
Bambha KM; Dodge JL; Gralla J; Sprague D; Biggins SW
Liver Transpl; 2015 Oct; 21(10):1286-94. PubMed ID: 26097202
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
Taniguchi M
Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
